ADGRG2 and hepatocellular carcinoma: In short, we considered miR-326 can serve as a marker for the diagnosis of HCC in combination with ADGRG2, and we discovered for the first time that miR-326 can target AGDGR2 to inhibit the proliferation and migration of the HCC cells Huh7 and HepG2, which are related to NETs.